F2G vs Solid Biosciences
F2G is the older company (1998 vs 2013).
Side-by-Side Comparison
| Metric | F2G | Solid Biosciences |
|---|---|---|
| Founded | ||
| Founded | 1998 older | 2013 |
| Headquarters | ||
| Headquarters | Manchester, United Kingdom | Boston, United States |
| Employees | ||
| Employees | 106 | 161 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $267.42M | $610.30M |
| Funding Rounds | ||
| Funding Rounds | 13 | 9 |
| Services | ||
| Services | Development of Antifungal Therapies, Research and Development in Fungal Infections, Early Access to Investigational Therapies | Gene Therapy Development, Clinical Trials, Research Collaborations, Licensing Opportunities, Manufacturing Infrastructure |
| Target Customers | ||
| Target Customers | Patients with Rare Fungal Infections, Healthcare Providers, Medical Researchers | Patients with Rare Neuromuscular Diseases, Patients with Cardiac Diseases, Medical Researchers, Healthcare Providers, Biotechnology Collaborators |
| Taxonomy | ||
| Taxonomy | BiopharmaceuticalClinical-stageFungal DiseaseOrotomidesAntifungal AgentsInvasive Fungal Infections +9 | Precision Genetic MedicineGene TherapyRare Neuromuscular DiseasesCardiac DiseasesDuchenne Muscular DystrophyFriedreich’s Ataxia +9 |
| Website | ||
| Website | f2g.com | solidbio.com |
About F2G
F2G, known as "The rare fungal disease company," is a pioneering clinical-stage biopharmaceutical firm headquartered in the United Kingdom. Founded in 1998, the company is at the forefront of developing therapies for life-threatening invasive fungal infections. Central to F2G's innovation is the cre...
About Solid Biosciences
Solid Biosciences, founded in 2013 and headquartered in Charlestown, MA, USA, is a trailblazer in the biotechnology sector, especially in precision genetic medicine. Their motto, #TogetherWeAreSolid, reflects their commitment to advancing gene therapy solutions for rare neuromuscular and cardiac dis...
Also comparing in this category
Comparing more than these two?
Get F2G, Solid Biosciences and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does F2G compare?
A PDF of F2G and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare F2G with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at F2G on 11 Mar 2026, and Solid Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.